Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Clin Infect Dis. 2013 Jun 24;57(7):923–928. doi: 10.1093/cid/cit429

Table 1.

Demographic and Clinical Characteristics of Unmatched and Matched Cohorts

Summary Statistics Mortality Rates


Unmatched Cohort (No.a) Matched Cohort (No.a) Unmatched Cohort (No.a) Matched Cohort (No.a)




Characteristic ET Non-ET P Value ET Non-ET P Value ET Non-ET ET Non-ET

Age, yb,c (mean) 38.0 (105) 37.9 (704) .97 37.0 (101) 37.3 (314) .91
Female sexb 54.8 (104) 66.8 (683) .02 54.5 (101) 59.6 (314) .37 12.3 (7) 11.2 (51) 12.7 (7) 17.1 (32)
Pregnant 2.9 (35) 9.5 (168) .20 2.9 (34) 6.0 (83) .49 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0)
Prophylaxis taken 17.9 (106) 14.1 (711) .29 17.8 (101) 17.2 (314) .89 10.5 (2) 14.0 (14) 11.1 (2) 25.9 (14)
Antimalarial regimen receivedb,d 22.9 (105) 43.3 (711) <.0001 22.8 (101) 23.9 (314) .82 20.8 (5) 6.8 (21) 21.7 (5) 12.0 (9)
Acute respiratory distress syndromeb 22.6 (106) 22.4 (711) .95 23.8 (101) 22.0 (314) .71 16.7 (4) 13.2 (21) 16.7 (4) 15.9 (11)
Cerebral malariab,c 69.8 (106) 37.3 (711) <.0001 69.3 (101) 63.7 (314) .30 17.6 (13) 17.7 (47) 17.1 (12) 19.5 (39)
Renal failureb,c 43.4 (106) 44.4 (711) .84 41.6 (101) 43.0 (314) .80 30.4 (14) 14.2 (45) 31.0 (13) 25.2 (34)
Plasmodium falciparum speciesb 98.1 (104) 84.8 (652) .0002 98.0 (101) 97.8 (314) .88 17.6 (18) 11.8 (65) 17.2 (17) 16.3 (50)
Hospital typeb
 Teaching 43.4 (106) 30.0 (711) .006 45.5 (101) 35.0 (314) .06 8.7 (4) 5.6 (12) 8.7 (4) 6.4 (7)
 >200-bed community 21.7 (106) 26.2 (711) .33 19.8 (101) 21.3 (314) .74 21.7 (5) 10.8 (20) 25.0 (5) 19.4 (13)
 100–200-bed community 5.7 (106) 8.3 (711) .35 5.9 (101) 4.1 (314) .45 33.3 (2) 3.4 (2) 33.3 (2) 20.0 (1)
 <100-bed community 1.9 (106) 3.1 (711) .49 2.0 (101) 2.5 (314) .75 0.0 (0) 4.5 (1) 0.0 (0) 12.5 (1)
 Unknown 27.4 (106) 32.5 (711) .29 26.7 (101) 36.9 (314) .06 27.6 (8) 16.5 (38) 25.9 (7) 24.1 (28)
Possible immune statusb,c
 Possibly semi-immune 31.1 (106) 41.8 (711) .04 30.7 (101) 28.3 (314) .65 12.1 (4) 5.7 (17) 12.9 (4) 6.7 (6)
 Possibly not immune 36.8 (106) 28.6 (711) .08 37.6 (101) 36.6 (314) .86 17.9 (7) 9.9 (20) 18.4 (7) 11.3 (13)
 Unknown 32.1 (106) 29.7 (711) .62 31.7 (101) 35.0 (314) .54 23.5 (8) 17.1 (36) 21.9 (7) 28.2 (31)
Parasite densityb
 <10% 1.9 (106) 8.0 (711) .02 2.0 (101) 2.9 (314) .63 0.0 (0) 7.0 (4) 0.0 (0) 22.2 (2)
 ≥10% 6.6 (106) 4.8 (711) .42 6.9 (101) 4.8 (314) .40 14.3 (1) 8.8 (3) 14.3 (1) 20.0 (3)
 Unknown 91.5 (106) 87.2 (711) .21 91.1 (101) 92.4 (314) .68 18.6 (18) 10.6 (66) 18.5 (17) 15.5 (45)
Propensity score (mean) 0.25 (101) 0.12 (711) 0.25 (101) 0.20 (314)

Data are presented as % (No.) unless otherwise indicated.

Abbreviation: ET, exchange transfusion.

a

Total No. differs for some characteristics because of missing data.

b

Characteristics used in propensityscore model.

c

Included as covariate in final outcome model.

d

Documented to have received a drug regimen recommended by the Centers for Disease Control and Prevention for malaria.